Finance

Beta
Lists
LXEO:NASDAQ
Lexeo Therapeutics Inc
5,14 USD
+1,18%
(+0,060) 1D
5,15 USD
+0,19% (+0,010)
After hours
Closed: 29-май, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LXEO...
Open
5,12 USD
High
5,25 USD
Low
4,95 USD
Mkt. cap
403,60 млн
Avg. vol.
735,31 миң
Volume
666,77 миң
52-wk high
10,99 USD
52-wk low
2,67 USD
EPS
-1,45 USD
Shares outstanding
78,52 млн
No. of employees
59
Open
5,12 USD
High
5,25 USD
Low
4,95 USD
Mkt. cap
403,60 млн
Avg. vol.
735,31 миң
Volume
666,77 миң
52-wk high
10,99 USD
52-wk low
2,67 USD
EPS
-1,45 USD
Shares outstanding
78,52 млн
No. of employees
59
News stories
From sources across the web
About Lexeo Therapeutics Inc
CEO-
Employees59
Founded2017
Headquarters-
Sector-
Websitelexeotx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
-
-
-
-
Cost of goods sold
14,72 млн
15,70 млн
16,21 млн
15,70 млн
Cost of revenue
14,72 млн
15,70 млн
16,21 млн
15,70 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,97 млн
5,95 млн
6,91 млн
6,63 млн
Operating expense
15,97 млн
5,95 млн
6,91 млн
6,63 млн
Total operating expenses
30,69 млн
21,65 млн
23,12 млн
22,33 млн
Operating income
-30,69 млн
-21,65 млн
-23,12 млн
-22,33 млн
Other non operating income
-14,00 миң
-9,00 миң
9,00 миң
-1,00 миң
EBT including unusual items
-26,10 млн
-20,28 млн
-20,92 млн
-20,20 млн
EBT excluding unusual items
-29,46 млн
-20,22 млн
-20,91 млн
-20,24 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26,10 млн
-20,28 млн
-20,92 млн
-20,20 млн
Net profit margin
-
-
-
-
Earnings per share
-0,68
-0,33
-0,27
-0,25
Interest and investment income
1,27 млн
1,46 млн
2,21 млн
2,11 млн
Interest expense
-25,00 миң
-22,00 миң
-20,00 миң
-17,00 миң
Net interest expenses
1,24 млн
1,43 млн
2,19 млн
2,10 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-30,55 млн
-21,50 млн
-22,96 млн
-22,18 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer